Not Yet RecruitingNot Applicable

A Cohort Study of Hydatidiform Mole

800 participantsStarted 2022-12-01

Plain-language summary

The purpose of this study is to construct a cohort for the hydatidiform mole.

Age range13 Years – 55 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Patients who are diagnosed with hydatidiform mole (including: complete hydatidiform mole/partial hydatidiform mole; one of twins with hydatidiform mole; ectopic pregnancy hydatidiform mole; macroscopic or microscopic hydatidiform changes indicating early complete or partial hydatidiform mole can not be excluded; atypical placental site nodule) for the first time;
✓. Age 13-55 years old;
✓. Obtain informed consent and sign an informed consent form

✕. Patients who are unable to cooperate with the investigation such as mental disorders or cognitive impairment
✕. No histopathology diagnosis;
✕. Patients with other malignancies

Malignant trophoblastic tumor

Timeframe: 4.5 years

NCT IDNCT05637892

SponsorWomen's Hospital School Of Medicine Zhejiang University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-12-01

Weiguo Lv, PhD